Pacific Biosciences of California Inc (PACB)
1.46
+0.06
(+4.29%)
USD |
NASDAQ |
Apr 18, 16:00
1.44
-0.02
(-1.37%)
After-Hours: 05:42
Pacific Biosciences of California Cash from Operations (TTM): -259.17M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -259.17M |
September 30, 2023 | -262.18M |
June 30, 2023 | -260.05M |
March 31, 2023 | -278.87M |
December 31, 2022 | -263.21M |
September 30, 2022 | -234.35M |
June 30, 2022 | -211.96M |
March 31, 2022 | -167.10M |
December 31, 2021 | -111.18M |
September 30, 2021 | -93.74M |
June 30, 2021 | -70.89M |
March 31, 2021 | -78.96M |
December 31, 2020 | 19.50M |
September 30, 2020 | 15.59M |
June 30, 2020 | 16.13M |
March 31, 2020 | 22.36M |
December 31, 2019 | -78.31M |
September 30, 2019 | -79.12M |
June 30, 2019 | -76.03M |
March 31, 2019 | -72.97M |
December 31, 2018 | -66.43M |
September 30, 2018 | -67.64M |
June 30, 2018 | -71.31M |
March 31, 2018 | -69.62M |
December 31, 2017 | -67.52M |
Date | Value |
---|---|
September 30, 2017 | -60.22M |
June 30, 2017 | -58.26M |
March 31, 2017 | -64.33M |
December 31, 2016 | -67.93M |
September 30, 2016 | -55.74M |
June 30, 2016 | -55.64M |
March 31, 2016 | -44.24M |
December 31, 2015 | -47.89M |
September 30, 2015 | -62.53M |
June 30, 2015 | -53.00M |
March 31, 2015 | -59.12M |
December 31, 2014 | -51.47M |
September 30, 2014 | -50.68M |
June 30, 2014 | -25.73M |
March 31, 2014 | -28.51M |
December 31, 2013 | -29.83M |
September 30, 2013 | -33.48M |
June 30, 2013 | -69.85M |
March 31, 2013 | -77.06M |
December 31, 2012 | -76.82M |
September 30, 2012 | -73.37M |
June 30, 2012 | -79.57M |
March 31, 2012 | -86.85M |
December 31, 2011 | -102.97M |
September 30, 2011 | -127.25M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-278.87M
Minimum
Mar 2023
22.36M
Maximum
Mar 2020
-129.03M
Average
-93.74M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
Integer Holdings Corp | 180.21M |
Cerus Corp | -43.17M |
Axogen Inc | -5.716M |
AVITA Medical Inc | -38.01M |
Intellia Therapeutics Inc | -394.09M |